JosephClaytonGatheJr.MDFACP FIDSA
Infectious Disease • Houston, TXHIV/AIDS Medicine
CEO Therapeutic Concepts
Dr. Gathe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4900 Fannin St
Houston, TX 77004Phone+1 713-526-9821Fax+1 713-526-0614
Education & Training
Baylor College of MedicineFellowship, Infectious Disease, 1985 - 1986- Baylor College of MedicineResidency, Internal Medicine, 1981 - 1984
- Baylor College of MedicineClass of 1981
Certifications & Licensure
TX State Medical License 1981 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- A Study to Compare Two Anti-HIV Drug Combinations Start of enrollment: 1999 Oct 01
- Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients Start of enrollment: 2005 Jun 01
- A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects Start of enrollment: 2010 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 96 citationsA once-daily lopinavir/ritonavir-based regimen provides noninferior antiviral activity compared with a twice-daily regimen.Margaret A. Johnson, Joseph Gathe, Daniel Podzamczer, Jean-Michel Molina, Christian Naylor
Journal of Acquired Immune Deficiency Syndromes. 2006-10-01 - 441 citationsImmune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.Samuel A. Shelburne, Richard J. Hamill, Maria C. Rodriguez-Barradas, Stephen B. Greenberg, Robert L. Atmar
Medicine. 2002-05-23 - 269 citationsCo-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenof...Edwin DeJesus, Jürgen K. Rockstroh, Keith Henry, Jean-Michel Molina, Joseph Gathe
Lancet. 2012-06-30
Press Mentions
BEWARE: COVID-19 Is STILL HERE and on the Rise…Once AgainJuly 21st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
